These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9492043)

  • 1. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1.
    Ohlsson C; Kley N; Werner H; LeRoith D
    Endocrinology; 1998 Mar; 139(3):1101-7. PubMed ID: 9492043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.
    Rubinstein M; Idelman G; Plymate SR; Narla G; Friedman SL; Werner H
    Endocrinology; 2004 Aug; 145(8):3769-77. PubMed ID: 15131018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
    Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
    Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
    Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.
    Attias-Geva Z; Bentov I; Kidron D; Amichay K; Sarfstein R; Fishman A; Bruchim I; Werner H
    Eur J Cancer; 2012 Jul; 48(10):1570-80. PubMed ID: 22033326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.
    Shahrabani-Gargir L; Pandita TK; Werner H
    Endocrinology; 2004 Dec; 145(12):5679-87. PubMed ID: 15345673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene.
    Aiello A; Pandini G; Sarfstein R; Werner H; Manfioletti G; Vigneri R; Belfiore A
    Eur J Cancer; 2010 Jul; 46(10):1919-26. PubMed ID: 20335021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner.
    Attias Z; Werner H; Vaisman N
    Endocr Relat Cancer; 2006 Jun; 13(2):571-81. PubMed ID: 16728583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
    Idelman G; Glaser T; Roberts CT; Werner H
    J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.
    Girnita L; Girnita A; Brodin B; Xie Y; Nilsson G; Dricu A; Lundeberg J; Wejde J; Bartolazzi A; Wiman KG; Larsson O
    Cancer Res; 2000 Sep; 60(18):5278-83. PubMed ID: 11016658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
    Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
    Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.
    Maor SB; Abramovitch S; Erdos MR; Brody LC; Werner H
    Mol Genet Metab; 2000 Feb; 69(2):130-6. PubMed ID: 10720440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I increases rat peptide YY promoter activity through Sp1 binding sites.
    Wang G; Leiter AB; Englander EW; Greeley GH
    Endocrinology; 2004 Feb; 145(2):659-66. PubMed ID: 14592960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.
    Liefvendahl E; Arnqvist HJ
    Horm Metab Res; 2008 Jun; 40(6):369-74. PubMed ID: 18393172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.